Menu
GeneBe

11-102110910-C-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_001130145.3(YAP1):c.62C>T(p.Ser21Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000119 in 1,433,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

YAP1
NM_001130145.3 missense

Scores

2
2
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.94
Variant links:
Genes affected
YAP1 (HGNC:16262): (Yes1 associated transcriptional regulator) This gene encodes a downstream nuclear effector of the Hippo signaling pathway which is involved in development, growth, repair, and homeostasis. This gene is known to play a role in the development and progression of multiple cancers as a transcriptional regulator of this signaling pathway and may function as a potential target for cancer treatment. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08010724).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
YAP1NM_001130145.3 linkuse as main transcriptc.62C>T p.Ser21Leu missense_variant 1/9 ENST00000282441.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
YAP1ENST00000282441.10 linkuse as main transcriptc.62C>T p.Ser21Leu missense_variant 1/91 NM_001130145.3 P2P46937-1

Frequencies

GnomAD3 genomes
AF:
0.00000660
AC:
1
AN:
151614
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000167
AC:
1
AN:
60024
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
35224
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000476
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000125
AC:
16
AN:
1281464
Hom.:
0
Cov.:
31
AF XY:
0.00000951
AC XY:
6
AN XY:
631080
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000471
Gnomad4 NFE exome
AF:
0.0000107
Gnomad4 OTH exome
AF:
0.0000577
GnomAD4 genome
AF:
0.00000660
AC:
1
AN:
151614
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74044
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000264

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpOct 02, 2023Variant summary: YAP1 c.62C>T (p.Ser21Leu) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 1.7e-05 in 60024 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.62C>T in individuals affected with Uveal Coloboma-Cleft Lip And Palate-Intellectual Disability and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.57
Cadd
Benign
22
Dann
Uncertain
0.99
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.63
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.82
T;T;T;T;T;T;T
M_CAP
Uncertain
0.26
D
MetaRNN
Benign
0.080
T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N;N;N;N;N;N;N
MutationTaster
Benign
1.0
N;N;N;N;N
PrimateAI
Pathogenic
0.86
D
PROVEAN
Benign
-0.43
N;N;N;N;.;.;N
REVEL
Benign
0.065
Sift
Pathogenic
0.0
D;D;D;D;.;.;D
Sift4G
Benign
0.29
T;T;T;T;T;T;T
Polyphen
0.015, 0.025
.;B;.;.;.;B;B
Vest4
0.16
MutPred
0.28
Loss of phosphorylation at S21 (P = 0.005);Loss of phosphorylation at S21 (P = 0.005);Loss of phosphorylation at S21 (P = 0.005);Loss of phosphorylation at S21 (P = 0.005);Loss of phosphorylation at S21 (P = 0.005);Loss of phosphorylation at S21 (P = 0.005);Loss of phosphorylation at S21 (P = 0.005);
MVP
0.043
MPC
1.1
ClinPred
0.33
T
GERP RS
2.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.13
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs990765765; hg19: chr11-101981641; API